Archive: 2026/04
Paragraph IV Certifications: How Generics Challenge Patents Early
Learn how Paragraph IV certifications allow generic drug makers to challenge patents early under the Hatch-Wawman Act. Discover the legal process, financial stakes, and impact on drug pricing.
Recent Posts
Understanding the different forms of azithromycin
July 6, 2023
How to Prevent and Treat Abrasions in Athletes
November 8, 2023
Bone Damage and Cancer: A Comprehensive Guide
May 5, 2023
